Fig. 6From: Soluble CD40L is associated with increased oxidative burst and neutrophil extracellular trap release in Behçet’s diseaseCD40 ligand (CD40L) gene expression is increased in peripheral blood mononuclear cells (PBMCs) from patients with Behçet’s disease (BD). a Platelet expression of CD40L (mean fluorescence intensity [MFI]) was determined under basal conditions and after 5 minutes with 0.2 IU/ml thrombin by flow cytometry in healthy control subjects (HCs), patients with inactive Behçet’s disease (iBD), and patients with active Behçet’s disease (aBD). b Higher CD40L relative gene expression in PBMCs from patients with BD than in HCs was demonstrated by qRT-PCR, despite an inability to increase CD40L expression in BD cells after 3 h of stimulation with 10 ng/ml phorbol 12-myristate 13-acetate (PMA). c A higher number of CD4+CD40L+ T cells from patients with BD than from HCs after 3-h stimulation with 25 ng/ml PMA + 1.5 μM ionomycin, determined by flow cytometry. d and e The number of Mac-1+ neutrophils was constitutively increased in patients with BD (d) and monocytes (e), determined by flow cytometry. No difference in CD40 surface expression was observed. f Phosphorylated NF-κB p65 subunit expression in resting neutrophils and monocytes from patients with BD was significantly higher than in HCs. g Plasma from patients with BD exerted a stronger stimulus on phosphorylated NF-κB p65 subunit expression than HC plasma in normal neutrophils and monocytes. Bars represent mean ± SE. Statistical analysis was performed using one-way analysis of variance with the Bonferroni posttestBack to article page